Tenet Healthcare (Tenet Healthcare) GF Value

: $76.14 (As of Today)

View and export this data going back to 1976. Start your Free Trial

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-04-24), Tenet Healthcare's share price is $97.86. Tenet Healthcare's GF Value is $76.14. Therefore, Tenet Healthcare's Price-to-GF-Value for today is 1.29.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Tenet Healthcare is Modestly Overvalued.

Tenet Healthcare (NYSE:THC) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Tenet Healthcare's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	97.86	/	76.14
	=	1.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tenet Healthcare GF Value Related Terms

Thank you for viewing the detailed overview of Tenet Healthcare's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Tenet Healthcare (Tenet Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tenet Healthcare Corp (NYSE:THC) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

THC:Mexico THC1:Germany

Address

14201 Dallas Parkway, Dallas, TX, USA, 75254

Website

https://www.tenethealth.com

Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of June 2023) and over 550 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

Executives

Richard W Fisher	director
Roy Blunt	director	2702 LOVE FIELD DRIVE, HDQ 4GC, DALLAS TX 75235
Paola M Arbour	officer: EVP, Chief Information Officer	14201 DALLAS PARKWAY, DALLAS TX 75254
Stephen H Rusckowski	director	C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Thomas W Arnst	officer: EVP, Chief Admin. Officer & GC	14201 DALLAS PARKWAY, DALLAS TX 75254
Tammy Romo	director	C/O SOUTHWEST AIRINES CO., 2702 LOVE FIELD DR., DALLAS TX 75235
Daniel J Cancelmi	officer: Principal Accounting Officer	13737 NOEL ROAD, SUITE 100, DALLAS TX 75240
J Robert Kerrey	director	NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036
Richard J Mark	director	1901 CHOUTEAU AVENUE MC-1310, ST. LOUIS MO 63103
Ronald A Rittenmeyer	director	5400 LEGACY DRIVE, PLANO TX 75024
Lisa Y Foo	officer: EVP, Commercial Ops	14201 DALLAS PARKWAY, DALLAS TX 75254
Audrey T. Andrews	officer: SVP and General Counsel	1445 ROSS AVENUE, SUITE 1400, DALLAS TX 75202
Meghan Fitzgerald	director	C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Howard Hacker	officer: EVP, Chief Compliance Officer	14201 DALLAS PARKWAY, DALLAS TX 75254
Marie Quintana	officer: EVP, Marketing/Communications	14201 DALLAS PARKWAY, DALLAS TX 75254